Moreover, MTTP decreased and increased the proportion of AML cells in G1 (Ki67+/DAPI-) and G0 (Ki67−/DAPI−) phases of the cell cycle, respectively (Fig. 4F). This evidence concerns the gene MKI67 and acute myeloid leukemia.